Genetic risk variants in African Americans with multiple sclerosis

Objectives: To assess the association of established multiple sclerosis (MS) risk variants in 3,254 African Americans (1,162 cases and 2,092 controls). Methods: Human leukocyte antigen (HLA)-DRB1, HLA-DQB1, and HLA-A alleles were typed by molecular techniques. Single nucleotide polymorphism (SNP) genotyping was conducted for 76 MS-associated SNPs and 52 ancestry informative marker SNPs selected throughout the genome. Self-declared ancestry was refined by principal component analysis of the ancestry informative marker SNPs. An ancestry-adjusted multivariate model was applied to assess genetic associations. Results: The following major histocompatibility complex risk alleles were replicated: HLA-DRB1*15:01 (odds ratio [OR] = 2.02 [95% confidence interval: 1.54–2.63], p = 2.50e-07), HLA-DRB1*03:01 (OR = 1.58 [1.29–1.94], p = 1.11e-05), as well as HLA-DRB1*04:05 (OR = 2.35 [1.26–4.37], p = 0.007) and the African-specific risk allele of HLA-DRB1*15:03 (OR = 1.26 [1.05–1.51], p = 0.012). The protective association of HLA-A*02:01 was confirmed (OR = 0.72 [0.55–0.93], p = 0.013). None of the HLA-DQB1 alleles were associated with MS. Using a significance threshold of p < 0.01, outside the major histocompatibility complex region, 8 MS SNPs were also found to be associated with MS in African Americans. Conclusion: MS genetic risk in African Americans only partially overlaps with that of Europeans and could explain the difference of MS prevalence between populations.

[1]  H. Harbo,et al.  The genetics of multiple sclerosis: an up‐to‐date review , 2012, Immunological reviews.

[2]  A. Alcina,et al.  Genome-Wide Association Study of Multiple Sclerosis Confirms a Novel Locus at 5p13.1 , 2012, PloS one.

[3]  E. Pieroni,et al.  HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia , 2012, PloS one.

[4]  P. D. de Bakker,et al.  Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci , 2011, Annals of neurology.

[5]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[6]  I. James,et al.  HLA-DR allele polymorphism and multiple sclerosis in Chinese populations: a meta-analysis , 2011, Multiple sclerosis.

[7]  David Reich,et al.  Validation of a small set of ancestral informative markers for control of population admixture in African Americans. , 2011, American journal of epidemiology.

[8]  Francisco M De La Vega,et al.  Analyses of a set of 128 ancestry informative single-nucleotide polymorphisms in a global set of 119 population samples , 2011, Investigative Genetics.

[9]  S. Hauser,et al.  Aggregation of multiple sclerosis genetic risk variants in multiple and single case families , 2011, Annals of neurology.

[10]  Peter M Vallone,et al.  Evaluating Self-declared Ancestry of U.S. Americans with Autosomal, Y-chromosomal and Mitochondrial DNA , 2010, Human mutation.

[11]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[12]  Annette Lee,et al.  Refining the association of MHC with multiple sclerosis in African Americans. , 2010, Human molecular genetics.

[13]  L. Liang,et al.  Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis , 2010, Nature Genetics.

[14]  William S Bush,et al.  Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come. , 2010, American journal of human genetics.

[15]  Joshua M. Korn,et al.  Rapid Assessment of Genetic Ancestry in Populations of Unknown Origin by Genome-Wide Genotyping of Pooled Samples , 2010, PLoS genetics.

[16]  S. Gabriel,et al.  Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. , 2010, American journal of human genetics.

[17]  P. D. De Jager,et al.  Multiple sclerosis susceptibility alleles in African Americans , 2009, Genes and Immunity.

[18]  Pablo Moscato,et al.  Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 , 2009, Nature Genetics.

[19]  Ludwig Kappos,et al.  Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci , 2009, Nature Genetics.

[20]  Michael R. Johnson,et al.  Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. , 2009, Human molecular genetics.

[21]  S. Baranzini,et al.  Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis , 2009, The Journal of Immunology.

[22]  D. Reich,et al.  Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA. , 2009, Archives of neurology.

[23]  F. Mihara,et al.  Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis , 2008, Multiple sclerosis.

[24]  D. Craig,et al.  Identification of a Novel Risk Locus for Multiple Sclerosis at 13q31.3 by a Pooled Genome-Wide Scan of 500,000 Single Nucleotide Polymorphisms , 2008, PloS one.

[25]  Alkes L Price,et al.  Application of Ancestry Informative Markers to Association Studies in European Americans , 2008, PLoS genetics.

[26]  Loren Gragert,et al.  High-resolution HLA alleles and haplotypes in the United States population. , 2007, Human immunology.

[27]  S. Gabriel,et al.  Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.

[28]  Jan Hillert,et al.  HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis , 2007, PloS one.

[29]  A. Morris,et al.  The Inheritance of Resistance Alleles in Multiple Sclerosis , 2007, PLoS genetics.

[30]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[31]  David Reich,et al.  A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility , 2005, Nature Genetics.

[32]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[33]  J L Haines,et al.  Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis , 2004, Neurology.

[34]  S. Tishkoff,et al.  Implications of biogeography of human populations for 'race' and medicine , 2004, Nature Genetics.

[35]  J. Haines,et al.  Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis , 2004, Annals of neurology.

[36]  M. Daly,et al.  Methods for high-density admixture mapping of disease genes. , 2004, American journal of human genetics.

[37]  Scott M. Williams,et al.  A high-density admixture map for disease gene discovery in african americans. , 2004, American journal of human genetics.

[38]  G. Rosati,et al.  Clinical Neurology and Neurosurgery the Worldwide Prevalence of Multiple Sclerosis , 2022 .

[39]  E. Kahana.  Epidemiologic studies of multiple sclerosis: a review. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[40]  Silke Schmidt,et al.  Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. , 2004, American journal of human genetics.